AP2013007257A0 - Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl] - Google Patents

Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]

Info

Publication number
AP2013007257A0
AP2013007257A0 AP2013007257A AP2013007257A AP2013007257A0 AP 2013007257 A0 AP2013007257 A0 AP 2013007257A0 AP 2013007257 A AP2013007257 A AP 2013007257A AP 2013007257 A AP2013007257 A AP 2013007257A AP 2013007257 A0 AP2013007257 A0 AP 2013007257A0
Authority
AP
ARIPO
Prior art keywords
iodophenyl
difluoro
dihydroxy
methoxyphenyl
fluoro
Prior art date
Application number
AP2013007257A
Other languages
English (en)
Inventor
Agathe Christine Mayer
Peter Fey
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46172787&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2013007257(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AP2013007257A0 publication Critical patent/AP2013007257A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/71—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/82—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/28—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2013007257A 2011-05-27 2012-05-24 Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl] AP2013007257A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11167806 2011-05-27
PCT/EP2012/059717 WO2012163799A1 (en) 2011-05-27 2012-05-24 Chiral synthesis of n-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides

Publications (1)

Publication Number Publication Date
AP2013007257A0 true AP2013007257A0 (en) 2013-11-30

Family

ID=46172787

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007257A AP2013007257A0 (en) 2011-05-27 2012-05-24 Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]

Country Status (30)

Country Link
US (1) US9328066B2 (ja)
EP (1) EP2714652B8 (ja)
JP (1) JP5965993B2 (ja)
KR (1) KR101939682B1 (ja)
CN (1) CN103596921B (ja)
AP (1) AP2013007257A0 (ja)
AR (1) AR086553A1 (ja)
AU (1) AU2012264884B2 (ja)
BR (1) BR112013030387A2 (ja)
CA (1) CA2837162C (ja)
CL (1) CL2013003387A1 (ja)
CO (1) CO6862147A2 (ja)
CR (1) CR20130618A (ja)
CU (1) CU20130156A7 (ja)
DO (1) DOP2013000278A (ja)
EA (1) EA026550B1 (ja)
EC (1) ECSP13013042A (ja)
ES (1) ES2682247T3 (ja)
GT (1) GT201300294A (ja)
IL (1) IL228911A (ja)
MA (1) MA35159B1 (ja)
MX (1) MX362823B (ja)
MY (1) MY186875A (ja)
NZ (1) NZ616783A (ja)
PE (1) PE20140580A1 (ja)
SG (1) SG194544A1 (ja)
TN (1) TN2013000492A1 (ja)
TW (1) TWI551579B (ja)
UA (1) UA113850C2 (ja)
WO (1) WO2012163799A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013094546A1 (ja) * 2011-12-19 2013-06-27 住友化学株式会社 スルホン酸塩の製造方法
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
DE102005042742A1 (de) 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
BRPI0615838A2 (pt) * 2005-09-14 2011-05-31 Janssen Pharmaceutica Nv 5-oxo-5,8-dihidro-pirido-pirimidinas como inibidores de ofc-fms cinase
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2660546A1 (en) 2006-08-21 2008-02-28 Genentech, Inc. Aza-benzofuranyl compounds and methods of use
EP1900739A1 (en) 2006-08-30 2008-03-19 Cellzome Ag Diazolodiazine derivatives as kinase inhibitors
EP2184984A4 (en) * 2007-07-30 2013-07-24 Ardea Biosciences Inc N- (ARYLAMINO) ARYLSULFONAMIDE DERIVATIVES COMPRISING POLYMORPHS AS MEK INHIBITORS AND COMPOSITIONS, METHODS OF USE AND PREPARATION METHODS THEREOF
CN102134218A (zh) 2009-06-15 2011-07-27 凯美隆(北京)药业技术有限公司 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
EA026550B1 (ru) 2017-04-28
US20140155637A1 (en) 2014-06-05
CN103596921A (zh) 2014-02-19
ECSP13013042A (es) 2014-01-31
MX362823B (es) 2019-02-18
TN2013000492A1 (en) 2015-03-30
MY186875A (en) 2021-08-26
IL228911A (en) 2017-10-31
EP2714652B8 (en) 2018-09-05
MX2013013667A (es) 2014-08-01
DOP2013000278A (es) 2013-12-31
UA113850C2 (xx) 2017-03-27
EP2714652B1 (en) 2018-07-18
JP5965993B2 (ja) 2016-08-10
US9328066B2 (en) 2016-05-03
EP2714652A1 (en) 2014-04-09
AR086553A1 (es) 2014-01-08
IL228911A0 (en) 2013-12-31
CA2837162C (en) 2019-04-02
TW201249791A (en) 2012-12-16
CR20130618A (es) 2014-01-09
KR20140032433A (ko) 2014-03-14
CA2837162A1 (en) 2012-12-06
CO6862147A2 (es) 2014-02-10
BR112013030387A2 (pt) 2016-12-13
SG194544A1 (en) 2013-12-30
CL2013003387A1 (es) 2014-09-22
CU20130156A7 (es) 2014-02-28
AU2012264884A1 (en) 2013-11-07
GT201300294A (es) 2014-11-13
AU2012264884B2 (en) 2017-03-09
JP2014520087A (ja) 2014-08-21
PE20140580A1 (es) 2014-06-01
ES2682247T3 (es) 2018-09-19
MA35159B1 (fr) 2014-06-02
KR101939682B1 (ko) 2019-01-17
WO2012163799A1 (en) 2012-12-06
EA201301333A1 (ru) 2014-06-30
NZ616783A (en) 2016-01-29
TWI551579B (zh) 2016-10-01
CN103596921B (zh) 2016-08-03

Similar Documents

Publication Publication Date Title
ZA201903184B (en) Compositions, methods, and systems for the synthesis and use of imaging agents
ZA201503125B (en) One-pot method for the synthesis of cu-ssz-13, the compound obtained by the method and use thereof
PL2489670T3 (pl) Sposób wytwarzania związków chelatów aminokwasowych, związki chelatów aminokwasowych i zastosowanie związków chelatów aminokwasowych
IL220936A (en) Process for cosamide synthesis
EP2606139A4 (en) BIOCATALYSTS AND METHODS FOR SYNTHESIZING (1R, 2R) -2- (3,4-DIMETHOXYPHENYL ETHYL) CYCLOHEXANAMINE
EP2691396A4 (en) ENOPEPTINES, USES THEREOF, AND METHODS OF SYNTHESIZING THE SAME
IL231044B (en) Ionic tags for oligoribonucleotide synthesis
ZA201209328B (en) Method of synthesis of ferroquine by convergent reductive amination
IL224847B (en) Synthesis of oligoribonucleotides
IL229742A0 (en) Hyperforin analogues, methods for their production and their uses
EP2790697A4 (en) USE OF 4'-DESFERRITHIOCIN ANALOGS
IL228911A0 (en) Chiral synthesis of }n-4,3-difluoro-2[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[3,2-dihydroxy-propyl]cyclopropanesulfonamides
EP2593096A4 (en) DICLOFENAC SALT OF TRAMADOL
AP3609A (en) New process for the synthesis of agomelatine
GB201213861D0 (en) Method for the synthesis of 3, 5-dichloroanisole from 1, 3, 5-trichlorobenzene
PL390177A1 (pl) Sposób wytwarzania soli α-(N-acyloamino) alkilotrifenylofosfoniowych
SI2661423T1 (sl) Novi postopek sinteze agomelatina
EP2750706A4 (en) 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE
ZA201107792B (en) Process for the preparation of highly pure duloxetine hydrochloride
AU2012902916A0 (en) Amino acid analogues and methods for their synthesis
PL395980A1 (pl) Sposób syntezowania cząstek węglanu wapnia
GB201002412D0 (en) Carbonic anhydrase inhibitors